Janus Henderson Group PLC Zai Lab LTD Transaction History

Janus Henderson Group PLC

$188 Billion
Q4 2024

A detailed history of Janus Henderson Group PLC transactions in Zai Lab LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,567,892 shares of ZLAB stock, worth $222 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,567,892

Previous 8,760,074 25.02%

Holding current value

$222 Million

Previous $211 Million 18.66%

% of portfolio

0.09%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.61 - $33.18 $53.9 Million - $72.7 Million	-2,192,182 Reduced 25.02%	6,567,892 $172 Million
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $36.3 Million - $53.9 Million	2,232,507 Added 34.2%	8,760,074 $211 Million
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $28.8 Million - $45.2 Million	2,099,556 Added 47.42%	6,527,567 $113 Million
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $6.18 Million - $10.4 Million	387,729 Added 9.6%	4,428,011 $70.9 Million
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $4.66 Million - $6.21 Million	-202,944 Reduced 4.78%	4,040,282 $110 Million
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $12.6 Million - $17.5 Million	556,472 Added 15.09%	4,243,226 $103 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $45.9 Million - $72 Million	1,815,712 Added 97.04%	3,686,754 $102 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $8.35 Million - $13.3 Million	276,417 Added 17.33%	1,871,042 $62.2 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $5.79 Million - $10.1 Million	-259,838 Reduced 14.01%	1,594,625 $49 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $2.01 Million - $3.03 Million	-58,681 Reduced 3.07%	1,854,463 $63.4 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $44.3 Million - $95 Million	1,913,144 New	1,913,144 $66.4 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $866,486 - $1.66 Million	-15,783 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$105.0 - $178.37 $1.19 Million - $2.03 Million	-11,353 Reduced 41.84%	15,783 $1.66 Million
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $814,716 - $1.17 Million	-6,512 Reduced 19.35%	27,136 $4.8 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $123,744 - $187,875	-980 Reduced 2.83%	33,648 $4.49 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $662,402 - $1.09 Million	8,084 Added 30.46%	34,628 $4.69 Million
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $723,984 - $883,793	9,877 Added 59.26%	26,544 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $813,682 - $1.38 Million	16,667 New	16,667 $1.37 Million
Q4 2017 Feb 09, 2018	SELL	$21.23 - $34.09 $5.91 Million - $9.49 Million	-278,345 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $7.52 Million - $8.66 Million	278,345	278,345 $0

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.31B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Zai Lab LTD Transaction History